Annual CFI
$31.90 M
+$109.40 M+141.16%
December 1, 2023
Summary
- As of February 7, 2025, MYGN annual cash flow from investing activities is $31.90 million, with the most recent change of +$109.40 million (+141.16%) on December 1, 2023.
- During the last 3 years, MYGN annual CFI has risen by +$3.90 million (+13.93%).
- MYGN annual CFI is now -88.37% below its all-time high of $274.40 million, reached on December 31, 2021.
Performance
MYGN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$7.50 M
+$13.90 M+217.19%
September 1, 2024
Summary
- As of February 7, 2025, MYGN quarterly cash flow from investing activities is $7.50 million, with the most recent change of +$13.90 million (+217.19%) on September 1, 2024.
- Over the past year, MYGN quarterly CFI has increased by +$14.60 million (+205.63%).
- MYGN quarterly CFI is now -97.42% below its all-time high of $291.00 million, reached on September 30, 2021.
Performance
MYGN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$18.00 M
+$10.00 M+35.71%
September 1, 2024
Summary
- As of February 7, 2025, MYGN TTM cash flow from investing activities is -$18.00 million, with the most recent change of +$10.00 million (+35.71%) on September 1, 2024.
- Over the past year, MYGN TTM CFI has dropped by -$8.20 million (-83.67%).
- MYGN TTM CFI is now -105.99% below its all-time high of $300.30 million, reached on September 30, 2021.
Performance
MYGN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MYGN Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +141.2% | +205.6% | -83.7% |
| 3 y3 years | +13.9% | +121.1% | +76.8% |
| 5 y5 years | +111.1% | +204.2% | -32.4% |
MYGN Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -88.4% | +141.2% | -78.3% | +118.2% | -106.6% | +76.8% |
| 5 y | 5-year | -88.4% | +111.1% | -97.4% | +118.2% | -106.0% | +76.8% |
| alltime | all time | -88.4% | +111.1% | -97.4% | +102.7% | -106.0% | +93.7% |
Myriad Genetics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $7.50 M(-217.2%) | -$18.00 M(-35.7%) |
| Jun 2024 | - | -$6.40 M(-9.9%) | -$28.00 M(+185.7%) |
| Mar 2024 | - | -$7.10 M(-40.8%) | -$9.80 M(-130.7%) |
| Dec 2023 | $31.90 M(-141.2%) | -$12.00 M(+380.0%) | $31.90 M(+284.3%) |
| Sep 2023 | - | -$2.50 M(-121.2%) | $8.30 M(-62.6%) |
| Jun 2023 | - | $11.80 M(-65.9%) | $22.20 M(-1487.5%) |
| Mar 2023 | - | $34.60 M(-197.2%) | -$1.60 M(-97.9%) |
| Dec 2022 | -$77.50 M(-128.2%) | -$35.60 M(-412.3%) | -$77.50 M(+14.3%) |
| Sep 2022 | - | $11.40 M(-195.0%) | -$67.80 M(-132.0%) |
| Jun 2022 | - | -$12.00 M(-70.9%) | $211.80 M(-5.8%) |
| Mar 2022 | - | -$41.30 M(+59.5%) | $224.90 M(-18.0%) |
| Dec 2021 | $274.40 M(+880.0%) | -$25.90 M(-108.9%) | $274.40 M(-8.6%) |
| Sep 2021 | - | $291.00 M(>+9900.0%) | $300.30 M(+1037.5%) |
| Jun 2021 | - | $1.10 M(-86.6%) | $26.40 M(-25.8%) |
| Mar 2021 | - | $8.20 M(-52.0%) | $35.60 M(-18.2%) |
| Dec 2020 | $28.00 M(+45.1%) | - | - |
| Sep 2020 | - | $17.10 M(+66.0%) | $43.50 M(+125.4%) |
| Jun 2020 | $19.30 M(-106.7%) | $10.30 M(-55.8%) | $19.30 M(+43.0%) |
| Mar 2020 | - | $23.30 M(-423.6%) | $13.50 M(-199.3%) |
| Dec 2019 | - | -$7.20 M(+1.4%) | -$13.60 M(-6.2%) |
| Sep 2019 | - | -$7.10 M(-257.8%) | -$14.50 M(-94.9%) |
| Jun 2019 | -$286.40 M(+2369.0%) | $4.50 M(-218.4%) | -$286.40 M(+1.6%) |
| Mar 2019 | - | -$3.80 M(-53.1%) | -$282.00 M(+1.1%) |
| Dec 2018 | - | -$8.10 M(-97.1%) | -$278.90 M(+1.3%) |
| Sep 2018 | - | -$279.00 M(-3234.8%) | -$275.40 M(+2274.1%) |
| Jun 2018 | -$11.60 M(-92.1%) | $8.90 M(-1371.4%) | -$11.60 M(-28.4%) |
| Mar 2018 | - | -$700.00 K(-84.8%) | -$16.20 M(+170.0%) |
| Dec 2017 | - | -$4.60 M(-69.7%) | -$6.00 M(+71.4%) |
| Sep 2017 | - | -$15.20 M(-453.5%) | -$3.50 M(-97.6%) |
| Jun 2017 | -$146.30 M(+60.1%) | $4.30 M(-54.7%) | -$146.30 M(-24.7%) |
| Mar 2017 | - | $9.50 M(-552.4%) | -$194.40 M(-11.6%) |
| Dec 2016 | - | -$2.10 M(-98.7%) | -$220.00 M(-14.9%) |
| Sep 2016 | - | -$158.00 M(+260.7%) | -$258.40 M(+182.7%) |
| Jun 2016 | -$91.40 M(-323.5%) | -$43.80 M(+172.0%) | -$91.40 M(+81.3%) |
| Mar 2016 | - | -$16.10 M(-60.2%) | -$50.40 M(+436.2%) |
| Dec 2015 | - | -$40.50 M(-550.0%) | -$9.40 M(-142.0%) |
| Sep 2015 | - | $9.00 M(-421.4%) | $22.40 M(-45.2%) |
| Jun 2015 | $40.90 M(-339.2%) | -$2.80 M(-111.2%) | $40.90 M(+61.2%) |
| Mar 2015 | - | $24.90 M(-386.2%) | $25.37 M(-4527.6%) |
| Dec 2014 | - | -$8.70 M(-131.6%) | -$573.00 K(-103.0%) |
| Sep 2014 | - | $27.50 M(-250.0%) | $18.96 M(-210.9%) |
| Jun 2014 | -$17.10 M(-77.2%) | -$18.33 M(+1657.4%) | -$17.10 M(-79.3%) |
| Mar 2014 | - | -$1.04 M(-109.6%) | -$82.71 M(+146.3%) |
| Dec 2013 | - | $10.83 M(-226.6%) | -$33.59 M(-57.2%) |
| Sep 2013 | - | -$8.56 M(-89.8%) | -$78.46 M(+4.7%) |
| Jun 2013 | -$74.90 M(+92.6%) | -$83.94 M(-274.6%) | -$74.90 M(-8759.0%) |
| Mar 2013 | - | $48.08 M(-241.3%) | $865.00 K(-101.0%) |
| Dec 2012 | - | -$34.04 M(+580.1%) | -$91.03 M(+120.1%) |
| Sep 2012 | - | -$5.00 M(-38.8%) | -$41.36 M(+6.4%) |
| Jun 2012 | -$38.89 M(-28.5%) | -$8.17 M(-81.3%) | -$38.89 M(-57.6%) |
| Mar 2012 | - | -$43.82 M(-380.2%) | -$91.65 M(+1611.5%) |
| Dec 2011 | - | $15.63 M(-717.5%) | -$5.36 M(-92.7%) |
| Sep 2011 | - | -$2.53 M(-95.8%) | -$73.59 M(+35.3%) |
| Jun 2011 | -$54.39 M(-29.1%) | -$60.94 M(-243.5%) | -$54.39 M(-393.7%) |
| Mar 2011 | - | $42.48 M(-180.8%) | $18.52 M(-149.5%) |
| Dec 2010 | - | -$52.60 M(-415.5%) | -$37.39 M(-39.0%) |
| Sep 2010 | - | $16.67 M(+39.3%) | -$61.31 M(-20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2010 | -$76.67 M(-62.8%) | $11.97 M(-189.1%) | -$76.67 M(-43.0%) |
| Mar 2010 | - | -$13.43 M(-82.5%) | -$134.60 M(-3.2%) |
| Dec 2009 | - | -$76.52 M(-5932.5%) | -$139.03 M(-15.1%) |
| Sep 2009 | - | $1.31 M(-102.9%) | -$163.66 M(-20.7%) |
| Jun 2009 | -$206.34 M(+559.1%) | -$45.96 M(+157.5%) | -$206.34 M(+14.4%) |
| Mar 2009 | - | -$17.85 M(-82.4%) | -$180.36 M(+26.6%) |
| Dec 2008 | - | -$101.16 M(+144.6%) | -$142.49 M(+234.0%) |
| Sep 2008 | - | -$41.37 M(+107.0%) | -$42.66 M(+36.3%) |
| Jun 2008 | -$31.30 M(-33.0%) | -$19.98 M(-199.8%) | -$31.30 M(-55.1%) |
| Mar 2008 | - | $20.02 M(-1610.7%) | -$69.73 M(-15.8%) |
| Dec 2007 | - | -$1.32 M(-95.6%) | -$82.83 M(+3.1%) |
| Sep 2007 | - | -$30.02 M(-48.6%) | -$80.30 M(+71.8%) |
| Jun 2007 | -$46.74 M(-35.8%) | -$58.41 M(-943.8%) | -$46.74 M(-1404.2%) |
| Mar 2007 | - | $6.92 M(+475.9%) | $3.58 M(-128.8%) |
| Dec 2006 | - | $1.20 M(-66.1%) | -$12.43 M(-81.8%) |
| Sep 2006 | - | $3.55 M(-143.9%) | -$68.33 M(-6.2%) |
| Jun 2006 | -$72.83 M(-473.2%) | -$8.09 M(-11.0%) | -$72.83 M(+120.2%) |
| Mar 2006 | - | -$9.09 M(-83.4%) | -$33.08 M(+10.9%) |
| Dec 2005 | - | -$54.70 M(+5627.5%) | -$29.83 M(-216.9%) |
| Sep 2005 | - | -$955.00 K(-103.0%) | $25.51 M(+30.7%) |
| Jun 2005 | $19.52 M(-162.5%) | $31.66 M(-642.2%) | $19.52 M(-137.2%) |
| Mar 2005 | - | -$5.84 M(-1013.9%) | -$52.47 M(+37.0%) |
| Dec 2004 | - | $639.00 K(-109.2%) | -$38.31 M(-0.3%) |
| Sep 2004 | - | -$6.95 M(-82.8%) | -$38.44 M(+23.1%) |
| Jun 2004 | -$31.23 M(+161.0%) | -$40.32 M(-584.8%) | -$31.23 M(+252.7%) |
| Mar 2004 | - | $8.32 M(+1521.4%) | -$8.85 M(-44.9%) |
| Dec 2003 | - | $513.00 K(+93.6%) | -$16.06 M(-5.5%) |
| Sep 2003 | - | $265.00 K(-101.5%) | -$17.00 M(+42.1%) |
| Jun 2003 | -$11.96 M(-131.4%) | -$17.95 M(-1708.4%) | -$11.96 M(-427.0%) |
| Mar 2003 | - | $1.12 M(-360.7%) | $3.66 M(-75.6%) |
| Dec 2002 | - | -$428.00 K(-108.1%) | $14.99 M(-33.7%) |
| Sep 2002 | - | $5.30 M(-327.5%) | $22.59 M(-40.7%) |
| Jun 2002 | $38.09 M(-144.8%) | -$2.33 M(-118.7%) | $38.09 M(-245.9%) |
| Mar 2002 | - | $12.44 M(+73.5%) | -$26.10 M(-28.6%) |
| Dec 2001 | - | $7.17 M(-65.5%) | -$36.58 M(-26.0%) |
| Sep 2001 | - | $20.80 M(-131.3%) | -$49.45 M(-41.9%) |
| Jun 2001 | -$85.08 M(+1862.4%) | -$66.52 M(-3480.7%) | -$85.08 M(+300.2%) |
| Mar 2001 | - | $1.97 M(-134.5%) | -$21.26 M(-12.8%) |
| Dec 2000 | - | -$5.70 M(-61.6%) | -$24.37 M(+16.2%) |
| Sep 2000 | - | -$14.83 M(+450.9%) | -$20.97 M(+383.7%) |
| Jun 2000 | -$4.34 M(-196.3%) | -$2.69 M(+135.6%) | -$4.34 M(+359.8%) |
| Mar 2000 | - | -$1.14 M(-50.3%) | -$943.00 K(-84.3%) |
| Dec 1999 | - | -$2.30 M(-227.8%) | -$6.00 M(-184.5%) |
| Sep 1999 | - | $1.80 M(+157.1%) | $7.10 M(+57.8%) |
| Jun 1999 | $4.50 M(-266.7%) | $700.00 K(-111.3%) | $4.50 M(-381.3%) |
| Mar 1999 | - | -$6.20 M(-157.4%) | -$1.60 M(-142.1%) |
| Dec 1998 | - | $10.80 M(-1450.0%) | $3.80 M(-143.2%) |
| Sep 1998 | - | -$800.00 K(-85.2%) | -$8.80 M(+225.9%) |
| Jun 1998 | -$2.70 M(-157.4%) | -$5.40 M(+575.0%) | -$2.70 M(-42.6%) |
| Mar 1998 | - | -$800.00 K(-55.6%) | -$4.70 M(-622.2%) |
| Dec 1997 | - | -$1.80 M(-134.0%) | $900.00 K(-86.8%) |
| Sep 1997 | - | $5.30 M(-171.6%) | $6.80 M(+44.7%) |
| Jun 1997 | $4.70 M(-108.0%) | -$7.40 M(-254.2%) | $4.70 M(-61.2%) |
| Mar 1997 | - | $4.80 M(+17.1%) | $12.10 M(+65.8%) |
| Dec 1996 | - | $4.10 M(+28.1%) | $7.30 M(+128.1%) |
| Sep 1996 | - | $3.20 M | $3.20 M |
| Jun 1996 | -$59.00 M | - | - |
FAQ
- What is Myriad Genetics annual cash flow from investing activities?
- What is the all time high annual CFI for Myriad Genetics?
- What is Myriad Genetics annual CFI year-on-year change?
- What is Myriad Genetics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Myriad Genetics?
- What is Myriad Genetics quarterly CFI year-on-year change?
- What is Myriad Genetics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Myriad Genetics?
- What is Myriad Genetics TTM CFI year-on-year change?
What is Myriad Genetics annual cash flow from investing activities?
The current annual CFI of MYGN is $31.90 M
What is the all time high annual CFI for Myriad Genetics?
Myriad Genetics all-time high annual cash flow from investing activities is $274.40 M
What is Myriad Genetics annual CFI year-on-year change?
Over the past year, MYGN annual cash flow from investing activities has changed by +$109.40 M (+141.16%)
What is Myriad Genetics quarterly cash flow from investing activities?
The current quarterly CFI of MYGN is $7.50 M
What is the all time high quarterly CFI for Myriad Genetics?
Myriad Genetics all-time high quarterly cash flow from investing activities is $291.00 M
What is Myriad Genetics quarterly CFI year-on-year change?
Over the past year, MYGN quarterly cash flow from investing activities has changed by +$14.60 M (+205.63%)
What is Myriad Genetics TTM cash flow from investing activities?
The current TTM CFI of MYGN is -$18.00 M
What is the all time high TTM CFI for Myriad Genetics?
Myriad Genetics all-time high TTM cash flow from investing activities is $300.30 M
What is Myriad Genetics TTM CFI year-on-year change?
Over the past year, MYGN TTM cash flow from investing activities has changed by -$8.20 M (-83.67%)